<DOC>
	<DOCNO>NCT02631824</DOCNO>
	<brief_summary>Randomized clinical trial ass use augmentation treatment fragility intertrochanteric hip fracture improve radiologic clinical outcome patient age 65 year old 1 year surgery</brief_summary>
	<brief_title>Radiologic Clinical Outcomes Augmentation Fragility Intertrochanteric Hip Fracture Treatment</brief_title>
	<detailed_description>To determine use augmentation PMMA treatment fragility intertrochanteric hip fracture improve radiologic clinical outcome osteoporotic patient , investigator aim conduct multicentered , randomize , single-blinded clinical trial . All patient age 65 year old arrive emergency department two level-1 trauma center Bogotá , Colombia ; Hospital Universitario Fundación Santa Fe de Bogotá Hospital Infantil Universitario de San José , sustain fragility intertrochanteric hip fracture require open reduction internal fixation ( ORIF ) include . These patient must willing accept 1-year follow-up require sign inform consent agree participation study . For sample calculation two-tailed analysis alpha-level significance 0.05 , power 80 % ( β = 0.2 ) perform . A total 35 patient per group plus 30 % increase control loss follow-up calculate . This give total 90 patient ; 45 patient per group . Patients meet inclusion exclusion criterion recruit convenience sample arrive emergency department . Once include study , patient stratify age two group : patient age 65-85 year patient 85 year . Then , use block randomization , intervention ( augmentation ) randomly allocate order divide sample population intervention group ( ORIF + augmentation PMMA ) control group ( ORIF without augmentation ) . Randomization carry program `` Sealed Envelope '' ( http : //www.sealedenvelope.com ) generate list code ( code represent one patient ) randomly assigns either intervention control group . This list custody research assistant contact patient trial 's duration charge write allocation code seal , opaque envelope . Each envelope give surgeon procedure precise moment augmentation need , reveal whether augmentation perform . Medical care base Orthogeriatric Programs surgery perform orthopaedic surgeon clinical fellowship Orthopaedic Trauma . Patients blind treatment see follow-up visit 15 day , one month , 3 month , 6 month , 12 month procedure . The primary outcome change TAD measurement 1 year surgical procedure . The functional difference group measure secondary outcome . Outcomes ( primary secondary ) measure follow-up visit one month , 3 month , 6 month , 12 month procedure . Results analyze use STATA ® Data Analysis Statistical Software , version 13.1 . The sample 's demographic baseline characteristic describe use descriptive statistic . Continuous variable report arithmetic mean categorical variable report absolute value frequency distribution . For inferential analysis result , Shapiro Wilk W-Test use determine normality distribution value . If normality assumption meet , change TAD measurement analyze student t-test . If , non-parametric analogue ( Mann-Whitney U-test ) use . For categorical variable , X2 Fisher 's exact test use .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<criteria>patient arrive emergency department sustain fragility hip fracture radiographic diagnosis intertrochanteric fracture require open reduction internal fixation patient willing accept 1year followup signature inform consent polytrauma patient nonfragility hip fracture ( highenergy trauma ) hip fracture due primary metastatic tumour , open periprosthetic hip fracture patient history organ transplantation patient severe dementia . patient iatrogenic perforation hip joint procedure</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>fragility fracture</keyword>
	<keyword>hip fracture</keyword>
	<keyword>augmentation</keyword>
	<keyword>tip-apex distance</keyword>
</DOC>